Modulation of protein kinase C by curcumin; inhibition and activation switched by calcium ions

British Journal of Pharmacology

Volumn 150, Issue 2, 2007, Pages 200-208

  Mahmmoud, Y A ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Ca 2+ binding; Curcumin; Phosphorylation; PKC; Polyphenols

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM ION; CURCUMIN; ISOENZYME; PROTEIN KINASE C;

ARTICLE; AUTORADIOGRAPHY; CALCIUM BINDING; CONCENTRATION RESPONSE; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; LIPID MEMBRANE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; ANIMALS; AUTORADIOGRAPHY; BINDING SITES; CALCIUM; CALCIUM-TRANSPORTING ATPASES; CATALYTIC DOMAIN; CATIONS, DIVALENT; CELL MEMBRANE; CURCUMIN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ISOENZYMES; LIPOSOMES; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN SUBUNITS; STIMULATION, CHEMICAL;

EID: 33846531680     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706970     Document Type: Article

References (42)

1. Atwood CS, Moir RD, Huang X, Scarpa RC, Bacarra NME, Romano DM et al. (1998). Dramatic aggregation of Alzheimer Aβ by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem 273: 12817-12826.
2. Baginski ES, Foa PP, Zak B (1967). Microdetermination of inorganic phosphate, phospholipids, and total phosphate in biologic materials. Clin Chim 13: 326-332.
3. Baum L, Ng A (2004). Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models. J Alzheimer's Dis 6: 367-377.
4. Bazzi MD, Nelsestuen GL (1990). Protein kinase C interaction with calcium: a phospholipid-dependent process. Biochemistry 29: 7624-7630.
5. Bazzi MD, Nelsestuen GL (1991). Proteins that bind calcium in a phospholipid-dependent manner. Biochemistry 30: 971-979.
6. 2+ pumps by curcumin. Curcumin putatively stabilizes the interaction between the nucleotide-binding and phosphorylation domains in the absence of ATP. Eur J Biochem 268: 6318-6327.
7. Choi H, Chun Y-S, Kim S-W, Kim M-S, Park J-W (2006). Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: A mechanism of tumor growth inhibition. Mol Pharmacol 70: 1664-1671.
8. Cohen P (2002). Protein kinases - the major drug targets of the twenty-first century. Nat Rev Drug Discov 1: 309-315.
9. Cornelius F, Mahmmoud YA, Meischke L, Cramb G (2005). Functional significance of the shark Na,K-ATPase N-terminal domain. Is the structurally variable N-Terminus involved in tissue-specific regulation by FXYD proteins? Biochemistry 44: 13051-13062.
10. Dyer JL, Khan SZ, Bilmen JG, Hawtin SR, Wheatley M, Javed MU et al. (2002). Curcumin: a new cell-permeant inhibitor of the inositol 1,4,5-trisphosphate receptor. Cell Calcium 31: 45-52.
11. Egan ME, Glockner-Pagel J, Ambrose C, Cahill PA, Pappoe L, Balamuth N et al. (2002). Calcium-pump inhibitors induce functional surface expression of Delta F508-CFTR protein in cystic fibrosis epithelial cells. Nat Med 8: 485-492.
12. Egan ME, Pearson M, Weiner SA, Rajendran V, Rubin D, Glockner-Pagel J et al. (2004). Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science 304: 600-602.
13. Feschenko MS, Sweadner KJ (1994). Conformation-dependent phosphorylation of Na,K-ATPase by protein kinase A and protein kinase C. J Biol Chem 269: 30436-30444.
14. Feschenko MS, Sweadner KJ (1997). Phosphorylation of Na,K-ATPase by protein kinase C at Ser18 occurs in intact cells but does not result in direct inhibition of ATP hydrolysis. J Biol Chem 272: 17726-17733.
15. Gopalakrishna R, Jaken S (2000). Protein kinase C signalling and oxidative stress. Free Rad Biol Med 28: 1349-1361.
16. Grubb BR, Gabriel SE, Mengos A, Gentzsch M, Randell SH, Van Heeckeren AM et al. (2006). SERCA pump inhibitors do not correct biosynthetic arrest of deltaF508 CFTR in cystic fibrosis. Am J Respir Cell Mol Biol 34: 355-363.
17. Hasmeda M, Polya GM (1996). Inhibition of cyclic AMP-dependent protein kinase by curcumin. Phytochemistry 42: 599-605.
18. Joe B, Vijaykumar M, Lokesh BR (2004). Biological properties of curcumin - cellular and molecular mechanisms of action. Crit Rev Food Sci Nutr 44: 97-111.
19. 2+ differentially regulates conventional protein kinase Cs' membrane interaction and activation. J Biol Chem 272: 25959-25967.
20. Kishimoto A, Mikawa K, Hashimoto K, Yasuda I, Tanaka S, Tominaga M et al. (1989). Limited proteolysis of protein kinase C subspecies by calcium-dependent neutral protease (calpain). J Biol Chem 264: 4088-4092.
21. Laemmli UK (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
22. Lin JK, Chen YC, Huang YT, Lin-Shiau SY (1997). Suppression of protein kinase C and nuclear oncogene expression as possible molecular mechanisms of cancer. J Cell Biochem 28-29: 39-48.
23. Liu JY, Lin SJ, Lin JK (1993). Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells. Carcinogenesis 14: 857-861.
24. 2+. J Biol Chem 276: 46905-46911.
25. + occlusion, and inhibition of hydrolytic activity. Br J Pharmacol 145: 236-245.
26. Mahmmoud YA, Cornelius F (2002). Protein kinase C phosphorylation of purified Na,K-ATPase: C-terminal phosphorylation sites at the alpha- and gamma-subunits close to the inner face of the plasma membrane. Biophys J 82: 1907-1919.
27. Mahmmoud YA, Vorum H, Cornelius F (2000). Identification of a phospholemman-like protein from shark rectal glands. J Biol Chem 275: 35969-35977.
28. Mall M, Kunzelmann K (2005). Correction of the CF defect by curcumin: hypes and disappointments. Bioassays 27: 9-13.
29. 2+-binding proteins. Biochim Biophys Acta 298: 246-269.
30. Newton AC (2001). Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem Rev 101: 2353-2364.
31. Ng TP, Chiam PC, Lee T, Chua HC, Lim L, Kua EH (2006). Curry consumption and cognitive function in the elderly. Am J Epidemiol 164: 898-906.
32. Nishizuka Y (2003). Discovery and prospect of protein kinase C research: epilogue. J Biochem (Tokyo) 133: 155-158.
33. Reddy S, Aggarwal BB (1994). Curcumin is a non-competitive and selective inhibitor of phosphorylase kinase. FEBS Lett 341: 19-22.
34. + occlusion and dissociation of the M5/M6 fragment. J Biol Chem 273: 7311-7319.
35. Singh S, Aggarwal BB (1995). Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane). J Biol Chem 270: 24995-25000.
36. Singh S, Khar A (2006). Biological effects of curcumin and its role in cancer chemoprevention and therapy. Anticancer Agents Med Chem 6: 259-270.
37. Song Y, Sonawane ND, Salinas D, Qian L, Pedemonte N, Galietta LJ et al. (2004). Evidence against the rescue of defective DeltaF508-CFTR cellular processing by curcumin in cell culture and mouse models. J Biol Chem 279: 40629-40633.
38. 2+ pump and its control by anions and curcumin in skeletal and cardiac sarcoplasmic reticulum. J Biol Chem 277: 13900-13906.
39. Surh Y-J (2003). Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3: 768-780.
40. Szoka FC, Papahadjopoulos D (1980). Comparative properties and methods of preparation of lipid vesicles (liposomes). Ann Rev Biophys Bioeng 9: 467-508.
41. Zhang J, Anastasiadis PZ, Liu Y, Thompson EA, Fields AP (2004). Protein kinase C (PKC) βII induces cell invasion through a Ras/Mek-, PKC/Rac 1-dependent signaling pathway. J Biol Chem 279: 22118-22123.
42. Zheng J, Ramirez VD (2000). Inhibition of mitochondrial proton F0F1-ATPase/ATP synthase by polyphenolic phytochemicals. Br J Pharmacol 130: 1115-1123.